The aortic stent grafts market size is anticipated to grow to US$ 2.5 billion by 2023. At a 5% compound annual growth rate, the market is projected to reach US$ 4.2 billion by 2033.
An important driver is the aging population, which is growing. Aneurysms and other aortic disorders are more prevalent in elderly people. As the population ages, more aortic stent grafts are expected to be needed.
Smoking and hypertension are two lifestyle-related indicators that contribute to the rising prevalence of aortic illnesses. The high incidence of these risk factors raises the need for aortic stent grafts even higher.
Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-865
Minimally invasive treatment approaches, such as aortic stent grafts reduce patient trauma and post-operative period of recuperation. The requirement for these devices is increasing as the patient desires to shift toward less intrusive procedures.
Progressive advancement in the design, substances, and delivery systems of aortic stent grafts improve their efficacy and safety. Fenestrated and branching stent-grafts, for example, increase the number of patients who can be treated, driving market expansion.
Superior healthcare infrastructure in developing countries is increasing access to innovative medical equipment such as aortic stent grafts. As many patients have access to treatment choices, the potential for expansion in emerging economies is a significant market driver.
The aortic stent grafts industry in Germany is highlighted by an effective healthcare system that adheres to rigorous norms and embraces advanced medical technologies. As older age is a substantial risk factor for aortic illnesses, there is a growing requirement for aortic stent grafts as people age.
In Germany, minimally invasive endovascular techniques are preferred, with aortic stent grafts serving as a less invasive option to standard open surgery. This method results in fast patient recovery and a few post-operative problems.
Key Takeaways:
- The market for aortic stent grafts in the United Kingdom is expected to reach US$ 510 million by 2033.
- The market in China is estimated to reach US$ 512 million, expanding at a CAGR of 5% through 2033.
- The aortic stent grafts market in Japan is expected to develop significantly, reaching US$ 220 million by 2033.
- The aortic stent grafts market in Germany is expected to experience a 5.1% CAGR through 2033.
“The expanding popularity of testing procedures for early diagnosis of aneurysms, paired with an aging male population, is driving the demand for aortic stent transplants. Since aneurysms, notably AAA, are asymptomatic, early diagnosis may prevent rupture and allow specialists to begin appropriate treatment.”
Aortic Stents Grafts Market Size:
Competitive Analysis:
Significant participants in the aortic stent grafts industry are investing considerably in advancements in research. Apart from that, they dominate the business through a variety of expansion strategies such as associations, mergers, joint ventures, and creative innovations and credentials.
- Endologix LLC revealed the introduction and first implant of its ALTO® Abdominal Stent Graft in Canada on May 11, 2021, after the latest authorization from Health Canada.
- In March 2022, TERUMO Aortic announced that the PMDA had authorized the RelayPro thoracic stent graft system for the medical care of people in Japan with thoracic aortic aneurysms (TAA). This stent graft system is a contemporary thoracic stent graft with a low profile designed to treat thoracic aneurysms and treat affected people with limited accessibility.
Key Segments:
Product Type:
- Abdominal Aortic Stents Graft
- Thoracic Aortic Stents Graft
End User:
- Hospitals
- Ambulatory Surgical Centers/Outpatient Surgical Centers
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia & Pacific
- East Asia
- The Middle East & Africa
Unlock Tailored Insights: Customize Your Report for Maximum Impact:https://www.futuremarketinsights.com/customization-available/rep-gb-865
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
